nodes	percent_of_prediction	percent_of_DWPC	metapath
Halothane—ALB—acquired immunodeficiency syndrome	0.204	1	CbGaD
Halothane—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0474	0.0739	CbGbCtD
Halothane—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0328	0.0512	CbGbCtD
Halothane—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0311	0.0486	CbGbCtD
Halothane—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0308	0.0481	CbGbCtD
Halothane—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0308	0.0481	CbGbCtD
Halothane—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0279	0.0435	CbGbCtD
Halothane—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0234	0.0365	CbGbCtD
Halothane—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0214	0.0334	CbGbCtD
Halothane—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0211	0.033	CbGbCtD
Halothane—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0207	0.0323	CbGbCtD
Halothane—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0199	0.031	CbGbCtD
Halothane—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0173	0.027	CbGbCtD
Halothane—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0163	0.0254	CbGbCtD
Halothane—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0163	0.0254	CbGbCtD
Halothane—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0158	0.0247	CbGbCtD
Halothane—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0149	0.0232	CbGbCtD
Halothane—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0149	0.0232	CbGbCtD
Halothane—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0147	0.023	CbGbCtD
Halothane—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0147	0.023	CbGbCtD
Halothane—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0135	0.021	CbGbCtD
Halothane—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0135	0.021	CbGbCtD
Halothane—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0127	0.0198	CbGbCtD
Halothane—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0123	0.0193	CbGbCtD
Halothane—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0116	0.0181	CbGbCtD
Halothane—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0113	0.0176	CbGbCtD
Halothane—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0112	0.0174	CbGbCtD
Halothane—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0112	0.0174	CbGbCtD
Halothane—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0107	0.0167	CbGbCtD
Halothane—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0102	0.0159	CbGbCtD
Halothane—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0102	0.0159	CbGbCtD
Halothane—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0101	0.0157	CbGbCtD
Halothane—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00947	0.0148	CbGbCtD
Halothane—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00947	0.0148	CbGbCtD
Halothane—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00857	0.0134	CbGbCtD
Halothane—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00857	0.0134	CbGbCtD
Halothane—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0074	0.0115	CbGbCtD
Halothane—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00718	0.0112	CbGbCtD
Halothane—RHO—nerve—acquired immunodeficiency syndrome	0.00682	0.0569	CbGeAlD
Halothane—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00649	0.0101	CbGbCtD
Halothane—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00649	0.0101	CbGbCtD
Halothane—KCNJ6—nerve—acquired immunodeficiency syndrome	0.00638	0.0532	CbGeAlD
Halothane—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00623	0.00971	CbGbCtD
Halothane—RHO—retina—acquired immunodeficiency syndrome	0.00282	0.0235	CbGeAlD
Halothane—GABRQ—nerve—acquired immunodeficiency syndrome	0.0027	0.0225	CbGeAlD
Halothane—GRIN2A—nerve—acquired immunodeficiency syndrome	0.00219	0.0182	CbGeAlD
Halothane—ATP2C1—nerve—acquired immunodeficiency syndrome	0.00167	0.0139	CbGeAlD
Halothane—KCNK18—spinal cord—acquired immunodeficiency syndrome	0.00161	0.0134	CbGeAlD
Halothane—GRIN3B—lung—acquired immunodeficiency syndrome	0.0016	0.0133	CbGeAlD
Halothane—GNG2—skin of body—acquired immunodeficiency syndrome	0.0016	0.0133	CbGeAlD
Halothane—RHO—nervous system—acquired immunodeficiency syndrome	0.00153	0.0128	CbGeAlD
Halothane—RHO—central nervous system—acquired immunodeficiency syndrome	0.00148	0.0123	CbGeAlD
Halothane—KCNJ6—nervous system—acquired immunodeficiency syndrome	0.00143	0.012	CbGeAlD
Halothane—KCNJ6—central nervous system—acquired immunodeficiency syndrome	0.00138	0.0115	CbGeAlD
Halothane—KCNK18—nervous system—acquired immunodeficiency syndrome	0.00135	0.0113	CbGeAlD
Halothane—KCNK18—central nervous system—acquired immunodeficiency syndrome	0.0013	0.0109	CbGeAlD
Halothane—GNG2—lymphoid tissue—acquired immunodeficiency syndrome	0.00129	0.0108	CbGeAlD
Halothane—GLRA1—nervous system—acquired immunodeficiency syndrome	0.00126	0.0105	CbGeAlD
Halothane—GNG2—blood—acquired immunodeficiency syndrome	0.00122	0.0101	CbGeAlD
Halothane—GLRA1—central nervous system—acquired immunodeficiency syndrome	0.00121	0.0101	CbGeAlD
Halothane—KCNJ3—nervous system—acquired immunodeficiency syndrome	0.00118	0.00987	CbGeAlD
Halothane—GNG2—bone marrow—acquired immunodeficiency syndrome	0.00118	0.00982	CbGeAlD
Halothane—RHO—brain—acquired immunodeficiency syndrome	0.00117	0.00977	CbGeAlD
Halothane—KCNJ3—central nervous system—acquired immunodeficiency syndrome	0.00114	0.0095	CbGeAlD
Halothane—GNG2—vagina—acquired immunodeficiency syndrome	0.00113	0.00941	CbGeAlD
Halothane—KCNJ6—brain—acquired immunodeficiency syndrome	0.0011	0.00914	CbGeAlD
Halothane—GNG2—lung—acquired immunodeficiency syndrome	0.00107	0.0089	CbGeAlD
Halothane—GNG2—nervous system—acquired immunodeficiency syndrome	0.000988	0.00824	CbGeAlD
Halothane—GNG2—central nervous system—acquired immunodeficiency syndrome	0.000952	0.00793	CbGeAlD
Halothane—KCNJ3—brain—acquired immunodeficiency syndrome	0.000905	0.00755	CbGeAlD
Halothane—KCNK2—vagina—acquired immunodeficiency syndrome	0.000804	0.0067	CbGeAlD
Halothane—ND1—skin of body—acquired immunodeficiency syndrome	0.000762	0.00635	CbGeAlD
Halothane—Isoflurane—ALB—acquired immunodeficiency syndrome	0.000759	1	CrCbGaD
Halothane—GNG2—brain—acquired immunodeficiency syndrome	0.000755	0.0063	CbGeAlD
Halothane—KCNK10—nervous system—acquired immunodeficiency syndrome	0.000754	0.00628	CbGeAlD
Halothane—KCNK9—nervous system—acquired immunodeficiency syndrome	0.000749	0.00624	CbGeAlD
Halothane—GNG2—lymph node—acquired immunodeficiency syndrome	0.00073	0.00609	CbGeAlD
Halothane—KCNK10—central nervous system—acquired immunodeficiency syndrome	0.000726	0.00605	CbGeAlD
Halothane—KCNK9—central nervous system—acquired immunodeficiency syndrome	0.000721	0.00601	CbGeAlD
Halothane—KCNMA1—retina—acquired immunodeficiency syndrome	0.000706	0.00589	CbGeAlD
Halothane—GLRB—spinal cord—acquired immunodeficiency syndrome	0.0007	0.00583	CbGeAlD
Halothane—ATP2C1—retina—acquired immunodeficiency syndrome	0.000691	0.00576	CbGeAlD
Halothane—KCNK3—nervous system—acquired immunodeficiency syndrome	0.00068	0.00567	CbGeAlD
Halothane—GLRB—vagina—acquired immunodeficiency syndrome	0.000673	0.00561	CbGeAlD
Halothane—KCNN4—lymphoid tissue—acquired immunodeficiency syndrome	0.000656	0.00547	CbGeAlD
Halothane—KCNK3—central nervous system—acquired immunodeficiency syndrome	0.000655	0.00546	CbGeAlD
Halothane—KCNN4—digestive system—acquired immunodeficiency syndrome	0.000648	0.00541	CbGeAlD
Halothane—GLRB—lung—acquired immunodeficiency syndrome	0.000637	0.00531	CbGeAlD
Halothane—GRIN3A—nervous system—acquired immunodeficiency syndrome	0.000622	0.00519	CbGeAlD
Halothane—KCNN4—blood—acquired immunodeficiency syndrome	0.000618	0.00515	CbGeAlD
Halothane—ND1—lymphoid tissue—acquired immunodeficiency syndrome	0.000617	0.00514	CbGeAlD
Halothane—ND1—digestive system—acquired immunodeficiency syndrome	0.00061	0.00508	CbGeAlD
Halothane—ATP2C1—skin of body—acquired immunodeficiency syndrome	0.000606	0.00505	CbGeAlD
Halothane—GABRQ—nervous system—acquired immunodeficiency syndrome	0.000606	0.00505	CbGeAlD
Halothane—GRIN3A—central nervous system—acquired immunodeficiency syndrome	0.000599	0.00499	CbGeAlD
Halothane—KCNN4—bone marrow—acquired immunodeficiency syndrome	0.000598	0.00498	CbGeAlD
Halothane—GLRB—nervous system—acquired immunodeficiency syndrome	0.00059	0.00492	CbGeAlD
Halothane—GABRQ—central nervous system—acquired immunodeficiency syndrome	0.000584	0.00487	CbGeAlD
Halothane—GRIN2A—spinal cord—acquired immunodeficiency syndrome	0.000584	0.00487	CbGeAlD
Halothane—KCNK10—brain—acquired immunodeficiency syndrome	0.000576	0.0048	CbGeAlD
Halothane—KCNN4—vagina—acquired immunodeficiency syndrome	0.000573	0.00477	CbGeAlD
Halothane—KCNK9—brain—acquired immunodeficiency syndrome	0.000573	0.00477	CbGeAlD
Halothane—GLRB—central nervous system—acquired immunodeficiency syndrome	0.000568	0.00473	CbGeAlD
Halothane—ND1—bone marrow—acquired immunodeficiency syndrome	0.000562	0.00468	CbGeAlD
Halothane—GRIN2A—vagina—acquired immunodeficiency syndrome	0.000562	0.00468	CbGeAlD
Halothane—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000542	0.00452	CbGeAlD
Halothane—KCNN4—lung—acquired immunodeficiency syndrome	0.000541	0.00451	CbGeAlD
Halothane—KCNK2—brain—acquired immunodeficiency syndrome	0.000538	0.00449	CbGeAlD
Halothane—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000537	0.00448	CbGeAlD
Halothane—GABRG3—nervous system—acquired immunodeficiency syndrome	0.000531	0.00443	CbGeAlD
Halothane—KCNK2—lymph node—acquired immunodeficiency syndrome	0.00052	0.00434	CbGeAlD
Halothane—KCNK3—brain—acquired immunodeficiency syndrome	0.00052	0.00433	CbGeAlD
Halothane—GABRG3—central nervous system—acquired immunodeficiency syndrome	0.000511	0.00426	CbGeAlD
Halothane—ND1—lung—acquired immunodeficiency syndrome	0.000509	0.00424	CbGeAlD
Halothane—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000509	0.00424	CbGeAlD
Halothane—GABRG1—spinal cord—acquired immunodeficiency syndrome	0.000502	0.00419	CbGeAlD
Halothane—GRIN2A—nervous system—acquired immunodeficiency syndrome	0.000492	0.0041	CbGeAlD
Halothane—ATP5D—digestive system—acquired immunodeficiency syndrome	0.000491	0.0041	CbGeAlD
Halothane—ATP2C1—lymphoid tissue—acquired immunodeficiency syndrome	0.000491	0.00409	CbGeAlD
Halothane—GABRB1—spinal cord—acquired immunodeficiency syndrome	0.000487	0.00406	CbGeAlD
Halothane—ATP2C1—digestive system—acquired immunodeficiency syndrome	0.000485	0.00404	CbGeAlD
Halothane—GRIN3A—brain—acquired immunodeficiency syndrome	0.000476	0.00396	CbGeAlD
Halothane—GRIN2A—central nervous system—acquired immunodeficiency syndrome	0.000473	0.00395	CbGeAlD
Halothane—ND1—nervous system—acquired immunodeficiency syndrome	0.000471	0.00393	CbGeAlD
Halothane—GABRB1—vagina—acquired immunodeficiency syndrome	0.000469	0.00391	CbGeAlD
Halothane—ATP5D—blood—acquired immunodeficiency syndrome	0.000468	0.0039	CbGeAlD
Halothane—GABRQ—brain—acquired immunodeficiency syndrome	0.000463	0.00386	CbGeAlD
Halothane—ATP2C1—blood—acquired immunodeficiency syndrome	0.000462	0.00385	CbGeAlD
Halothane—ND1—central nervous system—acquired immunodeficiency syndrome	0.000454	0.00378	CbGeAlD
Halothane—ATP5D—bone marrow—acquired immunodeficiency syndrome	0.000453	0.00378	CbGeAlD
Halothane—ATP5D—spinal cord—acquired immunodeficiency syndrome	0.000451	0.00376	CbGeAlD
Halothane—GLRB—brain—acquired immunodeficiency syndrome	0.000451	0.00376	CbGeAlD
Halothane—ATP2C1—bone marrow—acquired immunodeficiency syndrome	0.000447	0.00373	CbGeAlD
Halothane—ATP2C1—spinal cord—acquired immunodeficiency syndrome	0.000445	0.00371	CbGeAlD
Halothane—GABRD—nervous system—acquired immunodeficiency syndrome	0.00044	0.00367	CbGeAlD
Halothane—GLRB—lymph node—acquired immunodeficiency syndrome	0.000436	0.00363	CbGeAlD
Halothane—ATP5D—vagina—acquired immunodeficiency syndrome	0.000434	0.00362	CbGeAlD
Halothane—ATP2C1—vagina—acquired immunodeficiency syndrome	0.000428	0.00357	CbGeAlD
Halothane—GABRD—central nervous system—acquired immunodeficiency syndrome	0.000423	0.00353	CbGeAlD
Halothane—GABRG1—nervous system—acquired immunodeficiency syndrome	0.000423	0.00353	CbGeAlD
Halothane—GABRA6—nervous system—acquired immunodeficiency syndrome	0.000421	0.00351	CbGeAlD
Halothane—GABRP—vagina—acquired immunodeficiency syndrome	0.00042	0.0035	CbGeAlD
Halothane—KCNMA1—lung—acquired immunodeficiency syndrome	0.000414	0.00345	CbGeAlD
Halothane—GABRB1—nervous system—acquired immunodeficiency syndrome	0.00041	0.00342	CbGeAlD
Halothane—ATP5D—lung—acquired immunodeficiency syndrome	0.00041	0.00342	CbGeAlD
Halothane—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00041	0.00341	CbGeAlD
Halothane—GABRA5—nervous system—acquired immunodeficiency syndrome	0.000408	0.0034	CbGeAlD
Halothane—GABRG1—central nervous system—acquired immunodeficiency syndrome	0.000407	0.0034	CbGeAlD
Halothane—GABRG3—brain—acquired immunodeficiency syndrome	0.000406	0.00338	CbGeAlD
Halothane—GABRA6—central nervous system—acquired immunodeficiency syndrome	0.000405	0.00338	CbGeAlD
Halothane—ATP2C1—lung—acquired immunodeficiency syndrome	0.000405	0.00338	CbGeAlD
Halothane—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000403	0.00336	CbGeAlD
Halothane—NPSR1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000401	0.0118	CbGpPWpGaD
Halothane—NPSR1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000401	0.0118	CbGpPWpGaD
Halothane—GABRP—lung—acquired immunodeficiency syndrome	0.000397	0.00331	CbGeAlD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000397	0.0117	CbGpPWpGaD
Halothane—GABRB1—central nervous system—acquired immunodeficiency syndrome	0.000395	0.00329	CbGeAlD
Halothane—GABRA5—central nervous system—acquired immunodeficiency syndrome	0.000393	0.00328	CbGeAlD
Halothane—GNG2—G-protein beta:gamma signalling—CSF2—acquired immunodeficiency syndrome	0.00039	0.0115	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00039	0.0115	CbGpPWpGaD
Halothane—KCNMA1—nervous system—acquired immunodeficiency syndrome	0.000383	0.0032	CbGeAlD
Halothane—KCNN4—brain—acquired immunodeficiency syndrome	0.000383	0.0032	CbGeAlD
Halothane—ATP5D—nervous system—acquired immunodeficiency syndrome	0.00038	0.00317	CbGeAlD
Halothane—GABRA3—nervous system—acquired immunodeficiency syndrome	0.00038	0.00317	CbGeAlD
Halothane—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000379	0.0111	CbGpPWpGaD
Halothane—GRIN2A—brain—acquired immunodeficiency syndrome	0.000376	0.00313	CbGeAlD
Halothane—ATP2C1—nervous system—acquired immunodeficiency syndrome	0.000375	0.00313	CbGeAlD
Halothane—KCNN4—lymph node—acquired immunodeficiency syndrome	0.00037	0.00309	CbGeAlD
Halothane—GABRA4—nervous system—acquired immunodeficiency syndrome	0.00037	0.00309	CbGeAlD
Halothane—KCNMA1—central nervous system—acquired immunodeficiency syndrome	0.000369	0.00308	CbGeAlD
Halothane—GABRG2—spinal cord—acquired immunodeficiency syndrome	0.000368	0.00306	CbGeAlD
Halothane—GABRB2—spinal cord—acquired immunodeficiency syndrome	0.000368	0.00306	CbGeAlD
Halothane—GABRA3—central nervous system—acquired immunodeficiency syndrome	0.000366	0.00305	CbGeAlD
Halothane—ATP5D—central nervous system—acquired immunodeficiency syndrome	0.000366	0.00305	CbGeAlD
Halothane—CYP2A6—vagina—acquired immunodeficiency syndrome	0.000366	0.00305	CbGeAlD
Halothane—ATP2C1—central nervous system—acquired immunodeficiency syndrome	0.000361	0.00301	CbGeAlD
Halothane—ND1—brain—acquired immunodeficiency syndrome	0.00036	0.003	CbGeAlD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000359	0.0106	CbGpPWpGaD
Halothane—GABRA4—central nervous system—acquired immunodeficiency syndrome	0.000357	0.00297	CbGeAlD
Halothane—GNG2—Myometrial Relaxation and Contraction Pathways—ACTG1—acquired immunodeficiency syndrome	0.000353	0.0104	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000352	0.0104	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.000349	0.0103	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.000349	0.0103	CbGpPWpGaD
Halothane—ND1—lymph node—acquired immunodeficiency syndrome	0.000348	0.0029	CbGeAlD
Halothane—CYP2A6—lung—acquired immunodeficiency syndrome	0.000346	0.00288	CbGeAlD
Halothane—GABRD—brain—acquired immunodeficiency syndrome	0.000336	0.0028	CbGeAlD
Halothane—GABRB2—lung—acquired immunodeficiency syndrome	0.000335	0.00279	CbGeAlD
Halothane—NPSR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00033	0.00971	CbGpPWpGaD
Halothane—GABRA1—spinal cord—acquired immunodeficiency syndrome	0.000325	0.00271	CbGeAlD
Halothane—GABRG1—brain—acquired immunodeficiency syndrome	0.000324	0.0027	CbGeAlD
Halothane—GABRA2—vagina—acquired immunodeficiency syndrome	0.000323	0.00269	CbGeAlD
Halothane—GABRA6—brain—acquired immunodeficiency syndrome	0.000322	0.00268	CbGeAlD
Halothane—GABRE—vagina—acquired immunodeficiency syndrome	0.00032	0.00267	CbGeAlD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000316	0.0093	CbGpPWpGaD
Halothane—GABRB1—brain—acquired immunodeficiency syndrome	0.000314	0.00262	CbGeAlD
Halothane—GABRA5—brain—acquired immunodeficiency syndrome	0.000312	0.0026	CbGeAlD
Halothane—GABRG2—nervous system—acquired immunodeficiency syndrome	0.00031	0.00258	CbGeAlD
Halothane—GABRB2—nervous system—acquired immunodeficiency syndrome	0.00031	0.00258	CbGeAlD
Halothane—NPSR1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000305	0.00897	CbGpPWpGaD
Halothane—GABRE—lung—acquired immunodeficiency syndrome	0.000303	0.00253	CbGeAlD
Halothane—RHO—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000302	0.00889	CbGpPWpGaD
Halothane—GABRB2—central nervous system—acquired immunodeficiency syndrome	0.000298	0.00249	CbGeAlD
Halothane—GABRG2—central nervous system—acquired immunodeficiency syndrome	0.000298	0.00249	CbGeAlD
Halothane—KCNMA1—brain—acquired immunodeficiency syndrome	0.000293	0.00244	CbGeAlD
Halothane—GNG2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000292	0.00858	CbGpPWpGaD
Halothane—ATP5D—brain—acquired immunodeficiency syndrome	0.00029	0.00242	CbGeAlD
Halothane—GABRA3—brain—acquired immunodeficiency syndrome	0.00029	0.00242	CbGeAlD
Halothane—ATP2C1—brain—acquired immunodeficiency syndrome	0.000287	0.00239	CbGeAlD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000286	0.00841	CbGpPWpGaD
Halothane—KCNMA1—lymph node—acquired immunodeficiency syndrome	0.000283	0.00236	CbGeAlD
Halothane—GABRA4—brain—acquired immunodeficiency syndrome	0.000283	0.00236	CbGeAlD
Halothane—GABRA2—nervous system—acquired immunodeficiency syndrome	0.000283	0.00236	CbGeAlD
Halothane—GABRB3—spinal cord—acquired immunodeficiency syndrome	0.000282	0.00235	CbGeAlD
Halothane—ATP5D—lymph node—acquired immunodeficiency syndrome	0.000281	0.00234	CbGeAlD
Halothane—GABRE—nervous system—acquired immunodeficiency syndrome	0.000281	0.00234	CbGeAlD
Halothane—RHO—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000279	0.0082	CbGpPWpGaD
Halothane—ATP2C1—lymph node—acquired immunodeficiency syndrome	0.000277	0.00231	CbGeAlD
Halothane—NPSR1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000275	0.00808	CbGpPWpGaD
Halothane—GABRA1—nervous system—acquired immunodeficiency syndrome	0.000274	0.00228	CbGeAlD
Halothane—RHO—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000273	0.00804	CbGpPWpGaD
Halothane—GABRA2—central nervous system—acquired immunodeficiency syndrome	0.000273	0.00227	CbGeAlD
Halothane—GABRE—central nervous system—acquired immunodeficiency syndrome	0.00027	0.00225	CbGeAlD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000269	0.0079	CbGpPWpGaD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000269	0.0079	CbGpPWpGaD
Halothane—GABRA1—central nervous system—acquired immunodeficiency syndrome	0.000263	0.0022	CbGeAlD
Halothane—RHO—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000262	0.00771	CbGpPWpGaD
Halothane—RHO—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000262	0.00771	CbGpPWpGaD
Halothane—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000261	0.00217	CbGeAlD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000259	0.00761	CbGpPWpGaD
Halothane—GABRB3—lung—acquired immunodeficiency syndrome	0.000257	0.00214	CbGeAlD
Halothane—RHO—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000256	0.00753	CbGpPWpGaD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000245	0.00721	CbGpPWpGaD
Halothane—CYP2A6—brain—acquired immunodeficiency syndrome	0.000245	0.00204	CbGeAlD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000243	0.00715	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000241	0.00708	CbGpPWpGaD
Halothane—GABRB3—nervous system—acquired immunodeficiency syndrome	0.000238	0.00198	CbGeAlD
Halothane—GABRG2—brain—acquired immunodeficiency syndrome	0.000237	0.00197	CbGeAlD
Halothane—GABRB2—brain—acquired immunodeficiency syndrome	0.000237	0.00197	CbGeAlD
Halothane—GABRB3—central nervous system—acquired immunodeficiency syndrome	0.000229	0.00191	CbGeAlD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000222	0.00652	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000218	0.0064	CbGpPWpGaD
Halothane—GABRA2—brain—acquired immunodeficiency syndrome	0.000216	0.0018	CbGeAlD
Halothane—GNG2—G beta:gamma signalling through PI3Kgamma—IL2—acquired immunodeficiency syndrome	0.000216	0.00636	CbGpPWpGaD
Halothane—GABRE—brain—acquired immunodeficiency syndrome	0.000215	0.00179	CbGeAlD
Halothane—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000211	0.00176	CbGeAlD
Halothane—GABRA1—brain—acquired immunodeficiency syndrome	0.000209	0.00174	CbGeAlD
Halothane—GABRA2—lymph node—acquired immunodeficiency syndrome	0.000209	0.00174	CbGeAlD
Halothane—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000209	0.00174	CbGeAlD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000208	0.00613	CbGpPWpGaD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000208	0.00613	CbGpPWpGaD
Halothane—GABRE—lymph node—acquired immunodeficiency syndrome	0.000207	0.00173	CbGeAlD
Halothane—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000207	0.00172	CbGeAlD
Halothane—GNG2—G-protein beta:gamma signalling—IL2—acquired immunodeficiency syndrome	0.000206	0.00606	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000205	0.00602	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000205	0.00602	CbGpPWpGaD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000205	0.00601	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.0002	0.00588	CbGpPWpGaD
Halothane—RHO—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000199	0.00586	CbGpPWpGaD
Halothane—CYP2B6—blood—acquired immunodeficiency syndrome	0.000199	0.00166	CbGeAlD
Halothane—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000198	0.00165	CbGeAlD
Halothane—CYP2C9—blood—acquired immunodeficiency syndrome	0.000197	0.00164	CbGeAlD
Halothane—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000196	0.00163	CbGeAlD
Halothane—ALB—brain—acquired immunodeficiency syndrome	0.000196	0.00163	CbGeAlD
Halothane—NPSR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000195	0.00573	CbGpPWpGaD
Halothane—ALB—lymph node—acquired immunodeficiency syndrome	0.000189	0.00158	CbGeAlD
Halothane—RHO—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000187	0.00549	CbGpPWpGaD
Halothane—CYP2E1—blood—acquired immunodeficiency syndrome	0.000186	0.00155	CbGeAlD
Halothane—NPSR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000184	0.00542	CbGpPWpGaD
Halothane—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000184	0.00154	CbGeAlD
Halothane—GABRB3—brain—acquired immunodeficiency syndrome	0.000182	0.00152	CbGeAlD
Halothane—NPSR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000181	0.00532	CbGpPWpGaD
Halothane—RHO—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00018	0.00528	CbGpPWpGaD
Halothane—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.00018	0.0015	CbGeAlD
Halothane—GNG2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000177	0.0052	CbGpPWpGaD
Halothane—CYP2B6—lung—acquired immunodeficiency syndrome	0.000174	0.00145	CbGeAlD
Halothane—RHO—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000169	0.00496	CbGpPWpGaD
Halothane—RHO—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000167	0.0049	CbGpPWpGaD
Halothane—CYP2E1—lung—acquired immunodeficiency syndrome	0.000163	0.00136	CbGeAlD
Halothane—GNG2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000163	0.0048	CbGpPWpGaD
Halothane—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000161	0.00134	CbGeAlD
Halothane—GNG2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00016	0.0047	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000159	0.00467	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000159	0.00467	CbGpPWpGaD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000159	0.00466	CbGpPWpGaD
Halothane—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000157	0.00131	CbGeAlD
Halothane—NPSR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000156	0.00458	CbGpPWpGaD
Halothane—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000155	0.00129	CbGeAlD
Halothane—RHO—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000155	0.00456	CbGpPWpGaD
Halothane—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000155	0.00129	CbGeAlD
Halothane—RHO—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000154	0.00452	CbGpPWpGaD
Halothane—GNG2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000153	0.00451	CbGpPWpGaD
Halothane—GNG2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000153	0.00451	CbGpPWpGaD
Halothane—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000151	0.00126	CbGeAlD
Halothane—RHO—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000151	0.00445	CbGpPWpGaD
Halothane—GNG2—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00015	0.00442	CbGpPWpGaD
Halothane—CYP3A4—blood—acquired immunodeficiency syndrome	0.00015	0.00125	CbGeAlD
Halothane—GNG2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00015	0.0044	CbGpPWpGaD
Halothane—CYP2D6—blood—acquired immunodeficiency syndrome	0.000148	0.00123	CbGeAlD
Halothane—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000146	0.00121	CbGeAlD
Halothane—RHO—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000143	0.0042	CbGpPWpGaD
Halothane—NPSR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00014	0.00413	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00014	0.00412	CbGpPWpGaD
Halothane—RHO—Disease—CCNT1—acquired immunodeficiency syndrome	0.000131	0.00385	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000124	0.00363	CbGpPWpGaD
Halothane—CYP2B6—brain—acquired immunodeficiency syndrome	0.000123	0.00103	CbGeAlD
Halothane—NPSR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000123	0.00362	CbGpPWpGaD
Halothane—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000122	0.00102	CbGeAlD
Halothane—RHO—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000121	0.00355	CbGpPWpGaD
Halothane—GNG2—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000121	0.00355	CbGpPWpGaD
Halothane—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.00012	0.000999	CbGeAlD
Halothane—ND1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000119	0.00351	CbGpPWpGaD
Halothane—ATP5D—Metabolism—TAT—acquired immunodeficiency syndrome	0.000119	0.00351	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000118	0.00347	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000118	0.00347	CbGpPWpGaD
Halothane—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000117	0.000977	CbGeAlD
Halothane—GNG2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000117	0.00343	CbGpPWpGaD
Halothane—CYP2E1—brain—acquired immunodeficiency syndrome	0.000116	0.000964	CbGeAlD
Halothane—NPSR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000116	0.0034	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000116	0.0034	CbGpPWpGaD
Halothane—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000115	0.000962	CbGeAlD
Halothane—NPSR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000112	0.00329	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000109	0.00321	CbGpPWpGaD
Halothane—RHO—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000109	0.0032	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000107	0.00314	CbGpPWpGaD
Halothane—GNG2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000105	0.00309	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000105	0.00309	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000105	0.00309	CbGpPWpGaD
Halothane—ATP5D—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000102	0.00298	CbGpPWpGaD
Halothane—ND1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000102	0.00298	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.87e-05	0.0029	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	9.58e-05	0.00282	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	9.54e-05	0.00281	CbGpPWpGaD
Halothane—GNG2—Metabolism—TAT—acquired immunodeficiency syndrome	9.42e-05	0.00277	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	9.28e-05	0.00273	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	9.28e-05	0.00273	CbGpPWpGaD
Halothane—CYP2D6—brain—acquired immunodeficiency syndrome	9.16e-05	0.000764	CbGeAlD
Halothane—RHO—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	9.16e-05	0.00269	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	9.16e-05	0.00269	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	9.14e-05	0.00269	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	9.07e-05	0.00267	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	8.97e-05	0.00264	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	8.97e-05	0.00264	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.84e-05	0.0026	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	8.8e-05	0.00259	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	8.67e-05	0.00255	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	8.66e-05	0.00255	CbGpPWpGaD
Halothane—GRIN2A—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	8.63e-05	0.00254	CbGpPWpGaD
Halothane—NPSR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	8.45e-05	0.00248	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	8.28e-05	0.00244	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	8.2e-05	0.00241	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	8.15e-05	0.0024	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	8.15e-05	0.0024	CbGpPWpGaD
Halothane—GNG2—Metabolism—AGPS—acquired immunodeficiency syndrome	8.01e-05	0.00236	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—IFNA1—acquired immunodeficiency syndrome	8e-05	0.00235	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	7.99e-05	0.00235	CbGpPWpGaD
Halothane—GNG2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	7.95e-05	0.00234	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	7.93e-05	0.00233	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	7.87e-05	0.00231	CbGpPWpGaD
Halothane—GNG2—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	7.86e-05	0.00231	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.3e-05	0.00215	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	7.2e-05	0.00212	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.2e-05	0.00212	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	7.06e-05	0.00208	CbGpPWpGaD
Halothane—RHO—Disease—CXCR4—acquired immunodeficiency syndrome	6.87e-05	0.00202	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	6.82e-05	0.00201	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.72e-05	0.00198	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.6e-05	0.00194	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—IL10—acquired immunodeficiency syndrome	6.5e-05	0.00191	CbGpPWpGaD
Halothane—GNG2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	6.38e-05	0.00188	CbGpPWpGaD
Halothane—GNG2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.36e-05	0.00187	CbGpPWpGaD
Halothane—GLRB—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	6.31e-05	0.00186	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—CSF2—acquired immunodeficiency syndrome	6.26e-05	0.00184	CbGpPWpGaD
Halothane—GNG2—Hemostasis—CSF2—acquired immunodeficiency syndrome	6.22e-05	0.00183	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.21e-05	0.00182	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.21e-05	0.00182	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	6.2e-05	0.00182	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	6.15e-05	0.00181	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	6.1e-05	0.00179	CbGpPWpGaD
Halothane—ATP2C1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.86e-05	0.00172	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.66e-05	0.00166	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.6e-05	0.00165	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.58e-05	0.00164	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.58e-05	0.00164	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.36e-05	0.00158	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.36e-05	0.00158	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	5.35e-05	0.00157	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.25e-05	0.00154	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.25e-05	0.00154	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	5.12e-05	0.00151	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.07e-05	0.00149	CbGpPWpGaD
Halothane—GLRA1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	4.99e-05	0.00147	CbGpPWpGaD
Halothane—GNG2—Myometrial Relaxation and Contraction Pathways—IL6—acquired immunodeficiency syndrome	4.98e-05	0.00146	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.84e-05	0.00142	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.81e-05	0.00142	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.81e-05	0.00142	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.76e-05	0.0014	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.76e-05	0.0014	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.72e-05	0.00139	CbGpPWpGaD
Halothane—RHO—Disease—CCR5—acquired immunodeficiency syndrome	4.71e-05	0.00138	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.65e-05	0.00137	CbGpPWpGaD
Halothane—NPSR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.58e-05	0.00135	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	4.35e-05	0.00128	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.25e-05	0.00125	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.16e-05	0.00122	CbGpPWpGaD
Halothane—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.15e-05	0.00122	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—ALB—acquired immunodeficiency syndrome	4.08e-05	0.0012	CbGpPWpGaD
Halothane—KCNMA1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	4.07e-05	0.0012	CbGpPWpGaD
Halothane—GNG2—Hemostasis—ALB—acquired immunodeficiency syndrome	4.05e-05	0.00119	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.99e-05	0.00117	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.93e-05	0.00116	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	3.87e-05	0.00114	CbGpPWpGaD
Halothane—GNG2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.83e-05	0.00113	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.66e-05	0.00108	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.62e-05	0.00107	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.61e-05	0.00106	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.6e-05	0.00106	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.57e-05	0.00105	CbGpPWpGaD
Halothane—RHO—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.55e-05	0.00104	CbGpPWpGaD
Halothane—GNG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.51e-05	0.00103	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	3.46e-05	0.00102	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	3.46e-05	0.00102	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.4e-05	0.000999	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.31e-05	0.000973	CbGpPWpGaD
Halothane—KCNMA1—Hemostasis—IL2—acquired immunodeficiency syndrome	3.31e-05	0.000973	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.3e-05	0.00097	CbGpPWpGaD
Halothane—GNG2—Hemostasis—IL2—acquired immunodeficiency syndrome	3.29e-05	0.000967	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.26e-05	0.00096	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.23e-05	0.000949	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—TAT—acquired immunodeficiency syndrome	3.2e-05	0.000942	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.99e-05	0.00088	CbGpPWpGaD
Halothane—RHO—Disease—CD4—acquired immunodeficiency syndrome	2.96e-05	0.00087	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	2.82e-05	0.000829	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.81e-05	0.000828	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.81e-05	0.000828	CbGpPWpGaD
Halothane—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	2.8e-05	0.000822	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	2.78e-05	0.000819	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.72e-05	0.000801	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—TAT—acquired immunodeficiency syndrome	2.58e-05	0.00076	CbGpPWpGaD
Halothane—GABRQ—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.55e-05	0.000751	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	2.53e-05	0.000744	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—TNF—acquired immunodeficiency syndrome	2.47e-05	0.000728	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.46e-05	0.000723	CbGpPWpGaD
Halothane—NPSR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.45e-05	0.000719	CbGpPWpGaD
Halothane—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	2.27e-05	0.000669	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	2.24e-05	0.000658	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.2e-05	0.000646	CbGpPWpGaD
Halothane—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	2.17e-05	0.00064	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.15e-05	0.000633	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.14e-05	0.00063	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.11e-05	0.00062	CbGpPWpGaD
Halothane—GABRG3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.1e-05	0.000618	CbGpPWpGaD
Halothane—ND1—Metabolism—ALB—acquired immunodeficiency syndrome	2.08e-05	0.000612	CbGpPWpGaD
Halothane—ATP5D—Metabolism—ALB—acquired immunodeficiency syndrome	2.08e-05	0.000612	CbGpPWpGaD
Halothane—GNG2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.08e-05	0.000611	CbGpPWpGaD
Halothane—GABRB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.07e-05	0.000609	CbGpPWpGaD
Halothane—GABRA1—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2e-05	0.000587	CbGpPWpGaD
Halothane—GABRA6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.96e-05	0.000576	CbGpPWpGaD
Halothane—GABRA4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.93e-05	0.000569	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.93e-05	0.000567	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.91e-05	0.00056	CbGpPWpGaD
Halothane—RHO—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.9e-05	0.000558	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.89e-05	0.000555	CbGpPWpGaD
Halothane—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	1.85e-05	0.000544	CbGpPWpGaD
Halothane—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	1.83e-05	0.000539	CbGpPWpGaD
Halothane—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	1.81e-05	0.000531	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	1.8e-05	0.000528	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.78e-05	0.000523	CbGpPWpGaD
Halothane—GABRB2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.77e-05	0.00052	CbGpPWpGaD
Halothane—GABRA5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.72e-05	0.000505	CbGpPWpGaD
Halothane—GABRA3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.69e-05	0.000496	CbGpPWpGaD
Halothane—GABRA2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.66e-05	0.000488	CbGpPWpGaD
Halothane—GABRB3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.65e-05	0.000485	CbGpPWpGaD
Halothane—GNG2—Metabolism—ALB—acquired immunodeficiency syndrome	1.64e-05	0.000483	CbGpPWpGaD
Halothane—GABRG2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.62e-05	0.000476	CbGpPWpGaD
Halothane—RHO—Disease—IL6—acquired immunodeficiency syndrome	1.6e-05	0.00047	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.53e-05	0.000449	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.51e-05	0.000445	CbGpPWpGaD
Halothane—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000433	CbGpPWpGaD
Halothane—NPSR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.44e-05	0.000425	CbGpPWpGaD
Halothane—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	1.44e-05	0.000422	CbGpPWpGaD
Halothane—GABRA1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.41e-05	0.000416	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	1.17e-05	0.000345	CbGpPWpGaD
Halothane—RHO—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.12e-05	0.000329	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.11e-05	0.000328	CbGpPWpGaD
Halothane—GNG2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.11e-05	0.000326	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	9.98e-06	0.000294	CbGpPWpGaD
Halothane—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	7.59e-06	0.000223	CbGpPWpGaD
Halothane—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.97e-06	0.000205	CbGpPWpGaD
Halothane—GNG2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.55e-06	0.000193	CbGpPWpGaD
Halothane—CYP2A6—Metabolism—ALB—acquired immunodeficiency syndrome	5.58e-06	0.000164	CbGpPWpGaD
Halothane—CYP2B6—Metabolism—ALB—acquired immunodeficiency syndrome	4.51e-06	0.000132	CbGpPWpGaD
Halothane—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	4.41e-06	0.00013	CbGpPWpGaD
Halothane—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.13e-06	9.21e-05	CbGpPWpGaD
Halothane—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	3.1e-06	9.13e-05	CbGpPWpGaD
Halothane—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.05e-06	6.02e-05	CbGpPWpGaD
